Investigation Overview
May 31, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Abeona Therapeutics Inc (NASDAQ:ABEO) was announced over potential breaches of fiduciary duties by certain officers and directors at Abeona Therapeutics.
The investigation by a law firm concerns whether certain Abeona Therapeutics officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Abeona Therapeutics Inc reported that its annual Total Revenue rose from $.93 million in 2014 to $1.04 million in 2015 and that its Net Loss declined from $26.78 million in 2014 to $14.53 million in 2015.
Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) declined from $8.76 per share in May 2015 to as low as $2.05 per share on March 1, 2016.
On May 31, 2016, NASDAQ:ABEO shares closed at $2.92 per share.